| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8836737 | Surgery | 2018 | 8 Pages |
Abstract
Synthetic high-density lipoprotein is a promising platform to improve the delivery of anticancer drug 4,19,27-triacetyl withalongolide A to neuroblastomas and neuroblastoma cancer stem cells through SR-B1 targeting in vitro and in vivo.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Chitra PhD, MBA, Peter T. MD, Rui PhD, Avinaash BS, Valerie P. MD, James J. PhD, Barbara N. PhD, Anna PhD, Mark S. MD, FACS,